Free Trial
→ $30 stock to buy before Starlink goes public (WATCH NOW!) (From Paradigm Press) (Ad)tc pixel Free AARD Stock Alerts

Aardvark Therapeutics (AARD) Institutional Ownership

Aardvark Therapeutics logo
$5.47 +0.20 (+3.80%)
Closing price 04:00 PM Eastern
Extended Trading
$5.31 -0.16 (-2.85%)
As of 05:21 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Compare

Institutional Ownership Changes (13F Filings) for Aardvark Therapeutics (NASDAQ:AARD)

Number of
Institutional Buyers
(last 12 months)
39
Total
Institutional Inflows
(last 12 months)
$70.48M
Number of
Institutional Sellers
(last 12 months)
6
Total
Institutional Outflows
(last 12 months)
$4.85M
Get AARD Insider Trade Alerts

Want to know when executives and insiders are buying or selling Aardvark Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Chart & View Institutional Buying and Selling Data

AARD Institutional Buying and Selling by Quarter

Aardvark Therapeutics Major Shareholders & Ownership History

Export
Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
5/5/2026Bank of New York Mellon Corp29,320$111K0.0%+30.8%0.134%
2/18/2026XTX Topco Ltd25,548$335K0.0%N/A0.117%
2/18/2026Superstring Capital Management LP69,496$912K0.5%N/A0.319%
2/18/2026Millennium Management LLC483,340$6.34M0.0%+51.2%2.220%
2/18/2026Balyasny Asset Management L.P.13,817$181K0.0%N/A0.063%
2/18/2026Bridgeway Capital Management LLC27,000$354K0.0%+22.7%0.124%
2/17/2026Schonfeld Strategic Advisors LLC50,131$658K0.0%-80.2%0.230%
2/17/2026Cantor Fitzgerald L. P.91,682$1.20M0.0%-5.2%0.421%
2/17/2026Trexquant Investment LP16,844$221K0.0%N/A0.077%
2/17/2026Jump Financial LLC34,575$454K0.0%N/A0.159%
2/17/2026Laurion Capital Management LP1,014,911$13.32M0.5%-3.3%4.662%
2/17/2026Diadema Partners LP15,882$208K0.0%N/A0.073%
2/17/2026Persistent Asset Partners Ltd4,231$56K0.0%N/A0.019%
2/16/2026Barclays PLC20,516$269K0.0%-48.6%0.094%
2/13/2026Walleye Capital LLC16,048$211K0.0%N/A0.074%
2/13/2026Charles Schwab Investment Management Inc.31,533$414K0.0%+121.4%0.145%
2/13/2026State Street Corp158,240$2.08M0.0%+70.1%0.727%
2/13/2026Wells Fargo & Company MN14,080$185K0.0%+259.5%0.065%
2/12/2026HRT Financial LP31,066$407K0.0%N/A0.143%
2/12/2026MetLife Investment Management LLC7,750$102K0.0%N/A0.036%
2/12/2026SymBiosis Capital Partners LLC476,595$6.26M6.0%N/A2.189%
2/12/2026Alps Advisors Inc.17,877$235K0.0%N/A0.082%
2/12/2026 Nuveen LLC41,022$538K0.0%N/A0.188%
2/11/2026Los Angeles Capital Management LLC20,837$273K0.0%N/A0.096%
2/11/2026Propel Bio Management LLC46,408$609K0.5%N/A0.213%
2/10/2026Goldman Sachs Group Inc.53,349$700K0.0%+181.9%0.245%
2/9/2026Geode Capital Management LLC297,865$3.91M0.0%+53.5%1.368%
1/29/2026 China Universal Asset Management Co. Ltd.3,548$47K0.0%N/A0.016%
12/1/2025Cantor Fitzgerald L. P.96,682$1.29M0.0%+26.1%0.444%
11/17/2025Laurion Capital Management LP1,049,721$13.95M0.2%+6.1%4.838%
11/17/2025Millennium Management LLC319,623$4.25M0.0%N/A1.473%
11/17/2025Citadel Advisors LLC1,359,883$18.07M0.0%+5.9%6.268%
11/17/2025Bank of America Corp DE23,930$318K0.0%+199.5%0.110%
11/17/2025Cantor Fitzgerald L. P.96,682$1.29M0.0%+26.1%0.446%
11/14/2025Schonfeld Strategic Advisors LLC253,752$3.37M0.0%-9.1%1.169%
11/14/2025Two Sigma Investments LP63,569$845K0.0%N/A0.293%
11/14/2025Bridgeway Capital Management LLC22,000$292K0.0%N/A0.101%
11/13/2025UBS Group AG54,728$727K0.0%+5.4%0.252%
11/13/2025BNP Paribas Financial Markets56,546$751K0.0%+59.3%0.261%
11/12/2025Cresset Asset Management LLC146,783$1.95M0.0%N/A0.676%
11/7/2025Vanguard Group Inc.555,721$7.39M0.0%+20.6%2.561%
11/3/2025New York State Common Retirement Fund3,823$51K0.0%-47.6%0.018%
8/15/2025Bank of America Corp DE7,989$108K0.0%+72.9%0.037%
8/15/2025Adage Capital Partners GP L.L.C.175,000$2.37M0.0%-30.0%0.806%
8/14/2025MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.3,091$42K0.0%N/A0.014%
8/13/2025New York State Common Retirement Fund7,300$99K0.0%N/A0.034%
8/8/2025Geode Capital Management LLC136,927$1.85M0.0%+129.7%0.631%
6/27/2025Goldman Sachs Group Inc.20,311$153K0.0%N/A0.094%
5/16/2025Goldman Sachs Group Inc.20,311$153K0.0%N/A0.094%
5/16/2025Cormorant Asset Management LP800,189$6.01M0.5%N/A3.688%
5/16/2025Adage Capital Partners GP L.L.C.250,000$1.88M0.0%N/A1.152%
5/15/2025Braidwell LP500,000$3.76M0.1%N/A2.305%
5/14/2025Walleye Capital LLC11,730$88K0.0%N/A0.054%
5/8/2025Decheng Capital LLC3,917,299$29.42M8.3%N/A18.055%


AARD Institutional Ownership - Frequently Asked Questions

Who are the largest shareholders of AARD shares?

During the previous two years, 41 institutional investors and hedge funds held shares of Aardvark Therapeutics. The most heavily invested institutionals were Decheng Capital LLC ($29.42M), Citadel Advisors LLC ($18.07M), Laurion Capital Management LP ($13.32M), Vanguard Group Inc. ($7.39M), Millennium Management LLC ($6.34M), SymBiosis Capital Partners LLC ($6.26M), and Cormorant Asset Management LP ($6.01M).Learn more on Aardvark Therapeutics' institutional investors.

Which institutional investors have been buying Aardvark Therapeutics' stock?

Of the 39 institutional investors that purchased Aardvark Therapeutics' stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Decheng Capital LLC ($3.92M), Cormorant Asset Management LP ($800.19K), Braidwell LP ($500K), Millennium Management LLC ($483.34K), SymBiosis Capital Partners LLC ($476.60K), Adage Capital Partners GP L.L.C. ($250K), and Geode Capital Management LLC ($181.16K).

How much institutional buying is happening at Aardvark Therapeutics?

Institutional investors have bought a total of 7,722,356 shares in the last 24 months. This purchase volume represents approximately $70.48M in transactions.

Which of Aardvark Therapeutics' major shareholders have been selling company stock?

The following institutional investors have sold Aardvark Therapeutics stock in the last 24 months: Schonfeld Strategic Advisors LLC ($229.13K), Adage Capital Partners GP L.L.C. ($75K), Laurion Capital Management LP ($34.81K), Barclays PLC ($19.41K), Cantor Fitzgerald L. P. ($5K), and New York State Common Retirement Fund ($3.48K).

How much institutional selling is happening at Aardvark Therapeutics?

Institutional investors have sold a total of 366,824 shares in the last 24 months. This volume of shares sold represents approximately $4.85M in transactions.


Related Companies

This page (NASDAQ:AARD) was last updated on 5/5/2026 by MarketBeat.com Staff.
From Our Partners
Iran's New Leader Just Said Something That Should Terrify Every American
Iran's Supreme Leader has declared the Strait of Hormuz closed as leverage against the U.S. - and with 40% of ...
American Alternative | Sponsoredtc pixel
Your book attached
Your Download Link (Expiring) If you still haven't downloaded the free Simple Options Trading For Beginners...
Profits Run | Sponsoredtc pixel
My feud with Zohran Mamdani
Emmy-winning analyst releases his next big story Whitney Tilson shocked the nation on 60 Minutes when he ac...
Stansberry Research | Sponsoredtc pixel
The $1.75T "Backdoor" ticker (NOT Starlink)
When the SpaceX IPO launches, most investors will already be too late. The real opportunity isn't the IPO itse...
Behind the Markets | Sponsoredtc pixel
Sell 99% of Your Stocks, Do THIS Instead…
Millionaire Trader Exposes: "The Single Stock Income Plan" With over 6,000 stocks on the market to choose ...
The Oxford Club | Sponsoredtc pixel
Trade this between 9:30 and 10:45 am EST
The first 75 minutes of the trading day may be the most overlooked window for consistent opportunities.If you ...
Base Camp Trading | Sponsoredtc pixel
Iran War Shock: What I Was Told In That Private Meeting
You’re Being LIED To About The Iran War Forget EVERYTHING you’ve heard about the Iran war. Especially th...
Banyan Hill Publishing | Sponsoredtc pixel
Elon Unveils AI Passive Income Stream for Millions of Americans
During Tesla's last earnings call, Elon Musk outlined a new AI-driven approach he says could generate $30,000-...
InvestorPlace | Sponsoredtc pixel